EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Targeting ferroptosis in osteoporosis: mechanisms and natural products therapies

Zhanhong Cao, Chen Zhang, Xiaofan Yang, Yue Shen, Yuxin Bai

Frontiers in Pharmacology · 25.06.2026 · 17

DOI: 10.3389/fphar.2026.1726949 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Pharmacology, online erschienen am 25.06.2026. Verfasst von Zhanhong Cao und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Traditional Chinese Medicine, Bozhou University, Bozhou, Anhui, China. Die Arbeit nennt 215 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Osteoporosis (OP) persists as the principal contributor to the global disease burden. OP is defined by reduced bone mass and impaired bone microarchitecture, thereby weakening bone strength and elevating fracture risk. Imbalanced bone remodeling is the major pathological mechanism of OP, in which osteoclast-mediated bone resorption exceeds osteoblast-mediated bone formation. Iron serves as a vital micronutrient for numerous biochemical activities and is essential for many cellular processes. Ferroptosis is an iron-dependent form of modulated cell death with unique traits, including disrupted iron balance, compromised antioxidant defenses, and aberrant lipid peroxidation. Ferroptosis participates in various physiological and pathological processes, and its role in bone-related diseases, particularly OP, is increasingly being explored. Hence, a systematic examination of the mechanisms modulating ferroptosis in OP is imperative to pinpoint potential therapeutic targets and innovate novel therapeutic and/or preventive strategies. The agents currently used to treat OP have numerous side effects, prompting increased research on natural compounds for OP treatment. This review systematically summarizes the key features and modulation mechanisms of ferroptosis based on the latest research advances, and explores its pathogenic implications and therapeutic opportunities in OP. Additionally, we also discussed investigations of natural products in vitro and in vivo to prevent OP by interfering with ferroptosis.

Schlagwörter

Stichwörter der Autor:innen

antioxidant regulationferroptosisiron metabolismlipid peroxidationnatural productsosteoporosis

Autor:innen und Institutionen

  • School of Traditional Chinese Medicine, Bozhou University, Bozhou, Anhui, China.

Zitieren

APA

Cao, Z., Zhang, C., Yang, X., Shen, Y., & Bai, Y. (2026). Targeting ferroptosis in osteoporosis: mechanisms and natural products therapies. Frontiers in Pharmacology, 17. https://doi.org/10.3389/fphar.2026.1726949

Vancouver

Cao Z, Zhang C, Yang X, Shen Y, Bai Y. Targeting ferroptosis in osteoporosis: mechanisms and natural products therapies. Frontiers in Pharmacology. 2026;17. doi:10.3389/fphar.2026.1726949

BibTeX
@article{Cao2026,
  author = {Cao, Zhanhong and Zhang, Chen and Yang, Xiaofan and Shen, Yue and Bai, Yuxin},
  title = {Targeting ferroptosis in osteoporosis: mechanisms and natural products therapies},
  journal = {Frontiers in Pharmacology},
  year = {2026},
  volume = {17},
  doi = {10.3389/fphar.2026.1726949}
}
Kostenlos starten →